Impact of COVID-19 pandemic and vaccine perceptions on HPV vaccine hesitancy

Am J Otolaryngol. 2024 Mar-Apr;45(2):104172. doi: 10.1016/j.amjoto.2023.104172. Epub 2023 Dec 13.

Abstract

Objective: This study evaluated the impact of the COVID-19 pandemic and vaccine perceptions on Human Papillomavirus (HPV) vaccine hesitancy. Secondary endpoints included comparing COVID-19 and HPV vaccination trends regarding time, community of residence, and unmet social needs.

Methods: This was a survey-based, cross-sectional study that included 101 participants who were recruited through the Wyandotte County Public Health Department. Participants were eligible for inclusion in this study if they were a parent/guardian of one or more children aged 13 to 17; English- or Spanish-speaking. This study took place in Wyandotte County, Kansas. Descriptive statistics and chi-square analyses were utilized.

Results: There was no difference in completion of COVID-19 and HPV vaccines (p = 0.0975). Significantly more individuals started and did not finish the HPV vaccine series compared to the COVID-19 vaccine series (p = 0.0004). Most participants indicated their opinion on the HPV vaccine had not changed due to the pandemic (71.3 %). Participants who felt familiar with HPV had higher rates of HPV vaccine completion. While 77 % of participants felt extremely or moderately familiar with HPV, 61.4 % were unaware of its association with oropharyngeal cancer.

Conclusion: There was minimal change in parents' perception of the HPV vaccine due to the COVID-19 pandemic despite decreased rates of vaccination during this time. HPV vaccine series completion was significantly lower than COVID-19 vaccine series completion, highlighting a need to improve HPV vaccine completion counseling. Additionally, patient education should address the knowledge gap discovered regarding the link between HPV infection and oropharyngeal cancer.

Keywords: COVID-19; COVID-19 vaccines; Coronavirus; Health social determinants; Human papillomavirus viruses; Papillomavirus infections; Papillomavirus vaccines; SARS-CoV-2; Vaccination; Vaccination hesitancy; Vaccines.

MeSH terms

  • COVID-19 Vaccines
  • COVID-19* / epidemiology
  • COVID-19* / prevention & control
  • Child
  • Cross-Sectional Studies
  • Health Knowledge, Attitudes, Practice
  • Humans
  • Oropharyngeal Neoplasms*
  • Pandemics
  • Papillomavirus Infections* / epidemiology
  • Papillomavirus Infections* / prevention & control
  • Papillomavirus Vaccines*
  • Vaccination Hesitancy

Substances

  • Papillomavirus Vaccines
  • COVID-19 Vaccines